[Anti-ulcer action and peripheral opioid activity of the products of dalargin degradation].
D000818:Animals; D000897:Anti-Ulcer Agents / Q000378:metabolism / Q000627:therapeutic use*; D001711:Biotransformation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000378:metabolism; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006168:Guinea Pigs; D006868:Hydrolysis; D008297:Male; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects*; D013329:Structure-Activity Relationship
D000897:Anti-Ulcer Agents; D011957:Receptors, Opioid; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Protivoiazvennoe deĭstvie i perifericheskaia opioidnaia aktivnost' produktov degradatsii dalargina.